FilingReader Intelligence
Daito Pharmaceutical sales rise but profits plunge 33%
July 16, 2025 at 12:05 PM UTC•By FilingReader AI
Daito Pharmaceutical reported net sales of 50.64bn yen for the year ended May 2025, up 8.0% year-on-year. However, operating profit plunged 32.7% to 2.61bn yen due to product mix changes, increased depreciation and higher R&D costs.
The company forecasts net sales of 52.50bn yen and operating profit of 3.00bn yen for fiscal 2026.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
Primary Source Document
TSE:4577•Tokyo Stock Exchange
News Alerts
Get instant email alerts when Daito Pharmaceutical publishes news
Free account required • Unsubscribe anytime